(2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine
C18H21N — CID 146638964
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine
(2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine (PubChem CID 146638964) has the molecular formula C18H21N and a molecular weight of 251.37 g/mol. Its IUPAC name is (2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine.
Molecular Properties
| Compound Name | (2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine |
|---|---|
| PubChem CID | 146638964 |
| Molecular Formula | C18H21N |
| Molecular Weight | 251.37 g/mol |
| Exact Mass | 251.17 |
| IUPAC Name | (2E,4Z)-N-[(Z,1E)-1-(6-methylidenecyclohexa-2,4-dien-1-ylidene)but-2-enyl]hepta-2,4,6-trien-3-amine |
| SMILES | C=C/C=C\C(=C/C)NC(/C=C\C)=c1\ccccc1=C |
| InChI | InChI=1S/C18H21N/c1-5-8-13-16(7-3)19-18(11-6-2)17-14-10-9-12-15(17)4/h5-14,19H,1,4H2,2-3H3/b11-6-,13-8-,16-7+,18-17+ |
| InChIKey | LFWJARAZBLJKFB-LLHADGEQSA-N |
| XLogP | 3.02 |
| TPSA | 12.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 251.37 |
| LogP ≤ 5 | 3.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146638964 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.